Article
High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Malaria journal - 21 Apr 2014
Matondo Sungwa I, Temba Godfrey S, Kavishe Adelaida A, Kauki Julius S, Kalinga Akili, van Zwetselaar Marco, Reyburn Hugh, Kavishe Reginald A
Abstract excerpt
BACKGROUND: In 2006, the first-line anti-malarial drug treatment in Tanzania was changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (ALu), an artemisinin-based combination (ACT), since when the use of SP has been restricted for intermittent preventive treatment in pregnancy (IPTp). A number of Plasmodium falciparum mutations are known to be associated with resistance to SP, but it is not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
